Cited by 125Antifungal resistance and susceptibilityFungal and yeast genetics researchFungal Infections and Studies

Candida albicans Hyr1p Confers Resistance to Neutrophil Killing and Is a Potential Vaccine Target

Open access
Luo, Guanpingsheng, Ibrahim, Ashraf S., Spellberg, Brad, Nobile, Clarissa J., Mitchell, Aaron P., Fu, Yue·2010·The Journal of Infectious Diseases

Abstract

Candida albicans is the most common cause of invasive fungal infections in humans. It is unclear how C. albicans escapes from phagocytic attack and survives in the hostile blood environment during life-threatening systemic infections. Using a conditional overexpression or suppression genetic strategy, we discovered that HYR1 gene reduced phagocytic killing activity of C. albicans in vitro and increased tissue fungal burden in vivo. Concordant with its positive regulation by the transcription factor Bcr1p, autonomous expression of HYR1 complemented the hypersusceptibility to phagocyte-mediated killing of a bcr1 null mutant of C. albicans in vitro. As for C. albicans, heterologous expression of HYR1 in Candida glabrata rendered the organism more resistant to neutrophil killing activity. Vaccination with a recombinant Hyr1p significantly protected mice against hematogenously disseminated candidiasis (P = .001). Finally, anti-rHyr1p polyclonal antibodies enhanced mouse neutrophil killing activity by directly neutralizing rHyr1p effects in vitro. Thus, Hyr1 is an important virulence factor for C. albicans, mediating resistance to phagocyte killing. Hyr1p is a promising target for vaccine or other immunological or small molecule intervention to improve the outcomes of disseminated candidiasis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1086/652407

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 25

  1. [1]Spellberg BJ Filler SG Edwards JE Jr Current treatment strategies for disseminated candidiasis Clin Infect Dis 2006 42 244 251 16355336
  2. [2]Del Poeta M Role of phagocytosis in the virulence of Cryptococcus neoformans Eukaryot Cell 2004 3 1067 1075 15470235 PMC522596
  3. [4]Gulay Z Imir T Anti-candidial activity of natural killer (NK) and lymphokine activated killer (LAK) lymphocytes in vitro Immunobiology 1996 195 220 230 8877398
  4. [5]Baine WB Koenig MG Goodman JS Clearance of Candida albicans from the bloodstream of rabbits Infect Immun 1974 10 1420 1425 4611929 PMC423120
  5. [6]Louria DB Fallon N Browne HG The influence of cortisone on experimental fungus infections in mice J Clin Invest 1960 39 1435 1449 13763697 PMC293389
  6. [7]Meister H Heymer B Schafer H Haferkamp O Role of Candida albicans in granulomatous tissue reactions. II: In vivo degradation of C. albicans in hepatic macrophages of mice J Infect Dis 1977 135 235 242 320274
  7. [8]Stone HH Studies in the pathogenesis, diagnosis, and treatment of Candida sepsis in children J Pediatr Surg 1974 9 127 133 4204342
  8. [9]Taschdjian CL Toni EF Hsu KC Seelig MS Cuesta MB Kozinn PJ Immunofluorescence studies of Candida in human reticuloendothelial phagocytes: implications for immunogenesis and pathogenesis of systemic candidiasis Am J Clin Pathol 1971 56 50 58 4104089
  9. [10]Richard M Ibata-Ombetta S Dromer F Bordon-Pallier F Jouault T Gaillardin C Complete glycosylphosphatidylinositol anchors are required in Candida albicans for full morphogenesis, virulence, and resistance to macrophages Mol Microbiol 2002 44 841 853 11994163
  10. [11]Bailey DA Feldmann PJ Bovey M Gow NA Brown AJ The Candida albicans HYR1 gene, which is activated in response to hyphal development, belongs to a gene family encoding yeast cell wall proteins J Bacteriol 1996 178 5353 5360 8808922 PMC178351
  11. [12]Fu Y Luo G Spellberg BJ Edwards JEJ Ibrahim AS Gene overexpression/suppression analysis of candidate virulence factors of Candida albicans Eukaryot Cell 2008 7 483 492 18178776 PMC2268510
  12. [13]Nusing R Goerig M Habenicht AJ Ullrich V Selective eicosanoid formation during HL-60 macrophage differentiation. Regulation of thromboxane synthase Eur J Biochem 1993 212 371 376 8444174
  13. [14]Spellberg BJ Collins M French SW Edwards JE Jr Fu Y Ibrahim AS A phagocytic cell line markedly improves survival of infected neutropenic mice J Leukoc Biol 2005 78 338 344 15857941
  14. [15]Eiden-Plach A Zagorc T Heintel T Carius Y Breinig F Schmitt MJ Viral preprotoxin signal sequence allows efficient secretion of green fluorescent protein by Candida glabrata, Pichia pastoris, Saccharomyces cerevsiae, and Schizo- saccharomyces pombe Appl Environ Microbiol 2004 70 961 966 14766577 PMC348933
  15. [16]Avrova AO Venter E Birch PR Whisson SC Profiling and quantifying differential gene transcription in Phytophthora infestans prior to and during the early stages of potato infection Fungal Genet Biol 2003 40 4 14 12948509
  16. [17]Saville SP Lazzell AL Monteagudo C Lopez-Ribot JL Engineered control of cell morphology in vivo reveals distinct roles for yeast and filamentous forms of Candida albicans during infection Eukaryot Cell 2003 2 1053 1060 14555488 PMC219382
  17. [18]Spellberg B Ibrahim AS Yeaman MR The antifungal vaccine derived from the recombinant N terminus of Als3p protects mice against the bacterium Staphylococcus aureus Infect Immun 2008 76 4574 4580 18644876 PMC2546811
  18. [19]Ibrahim AS Spellberg BJ Avenissian V Fu Y Filler SG Edwards JE Jr Vaccination with rAls1p-N improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity Infect Immun 2005 73 999 1005 15664943 PMC547099
  19. [21]Nobile CJ Andes DR Nett JE Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo PLoS Pathog 2006 2 e63 10.1371/journal.ppat.0020063 Published 7 July 2006 16839200 PMC1487173 · DOI · Paper page
  20. [22]Fradin C De Groot P MacCallum D Granulocytes govern the transcriptional response, morphology and proliferation of Candida abicans in human blood Mol Microbiol 2005 56 397 415 15813733
  21. [23]Castano I Pan SJ Zupancic M Hennequin C Dujon B Cormack BP Telomere length control and transcriptional regulation of subtelomeric adhesins in Candida glabrata Mol Microbiol 2005 55 1246 1258 15686568
  22. [24]Schofield DA Westwater C Warner T Nicholas PJ Paulling EE Balish E Hydrolytic gene expression during oroesophageal and gastric candidiasis in immunocompetent and immunodeficient gnotobiotic mice J Infect Dis 2003 188 591 599 12898449
  23. [25]Kumamoto CA Vinces MD Contributions of hyphae and hypha-coregulated genes to Candida albicans virulence Cell Microbiol 2005 7 1546 1554 16207242
  24. [26]Frohner IE Bourgeois C Yatsyk K Majer O Kuchler K Candida albicans cell surface superoxide dismutases degrade host-derived reactive oxygen species to escape innate immune surveillance Mol Microbiol 2009 71 240 252 19019164 PMC2713856
  25. [27]Ibrahim AS Mirbod F Filler SG Evidence implicating phospholipase as a virulence factor of Candida albicans Infect Immun 1995 63 1993 8 7729913 PMC173255

Cited by

Sorted by citations

Authors
Luo, G., Ibrahim, A. S., Spellberg, B., Nobile, C. J., Mitchell, A. P., & Fu, Y.
Affiliations
  • The Lundquist Institute (US)
  • University of California, Los Angeles (US)
  • University of California, San Francisco (US)
  • Carnegie Mellon University (US)
Corresponding author
Fu, Yue
Venue
The Journal of Infectious Diseases
Published
2010-06
Volume
201
Issue
11
Pages
1718-1728
ISSN
  • 0022-1899 (ISSN-L)
  • 1537-6613
OpenAlex
W2049091194
Cited by
125
References
2
Citations by year
2026: 4 · 2025: 4 · 2024: 11 · 2023: 11 · 2022: 6 · 2021: 5 · 2020: 4 · 2019: 4 · 2018: 5 · 2017: 7 · 2016: 5 · 2015: 10 · 2014: 8 · 2013: 5 · 2012: 14
FWCI
8.50
Type
journal article
Language
en
Open access
Locations
  • The Journal of Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Allergy and Infectious Diseases (R03AI083251, R01AI067703, R21AI066010)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
Keywords
Candida albicans, phagocytosis, virulence factors, vaccine targets, systemic candidiasis, Candida glabrata, antibody neutralization, invasive fungal infections
MeSH terms
Animals, Candida albicans, Fungal Proteins, Fungal Vaccines, Liver, Mice, Inbred C57BL, Neutrophils, Spleen, Colony Count, Microbial, Survival Analysis, Virulence Factors, Microbial Viability, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review